XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 8,389 $ 7,405
Trade accounts receivable, net of allowance for doubtful accounts of $297 and $324, respectively 26,405 30,106
Inventories, net 28,064 29,759
Prepaid expenses and other current assets 2,144 3,103
Total current assets 65,002 70,373
Property, plant and equipment, net 22,713 22,525
Goodwill 26,459 26,753
Other intangible assets, net 9,250 9,721
Deferred income taxes, net 12,526 13,222
Other noncurrent assets 1,638 1,963
Total Assets 137,588 144,557
Current Liabilities:    
Accounts payable 7,766 9,388
Current portion of long-term debt 1,482 1,372
Accrued compensation and related benefits 1,382 1,655
Accrued expenses and other current liabilities 3,840 4,775
Total current liabilities 14,470 17,190
Long-term debt 9,284 15,780
Deferred income taxes 501 559
Other noncurrent liabilities 999 1,278
Total liabilities 25,254 34,807
Shareholders' equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,297,182 shares at June 30, 2020 and 20,268,050 shares at December 31, 2019; outstanding – 15,893,889 shares at June 30, 2020 and 15,866,868 shares at December 31, 2019 2,030 2,026
Capital in excess of par value 184,900 184,292
Accumulated deficit (50,113) (52,830)
Accumulated other comprehensive loss (3,296) (2,531)
Treasury stock - at cost; 4,403,293 shares at June 30, 2020 and 4,401,182 shares at December 31, 2019 (21,246) (21,231)
Total Ultralife Corporation equity 112,275 109,726
Non-controlling interest 59 24
Total shareholders’ equity 112,334 109,750
Total liabilities and shareholders' equity $ 137,588 $ 144,557